Anker SD, Butler J, Filippatos G, Khan MS, Marx N, Lam CSP, et al
No wonder the development of new weight loss drugs is such a hot topic
The FDA also raised concerns about contamination, incorrect dosages, unapproved or harmful ingredients, and counterfeit components in compounded GLP-1s
administration of propionyl-L-carnitine in humans, dogs and rats Eur J Drug Metab Pharmacokinet 1991
Routine monitoring during Saxenda treatment should include: Weight and BMI measurements : Regular assessment (typically monthly initially) to evaluate treatment response Blood glucose monitoring : Particularly important for patients with type 2 diabetes or prediabetes, as Saxenda may affect glycaemic control Heart rate : Saxenda can cause modest increases in resting heart rate